The Impact of "High-Producer" Interleukin-6 Haplotypes on Cardiovascular Morbidity and Mortality in a Kidney Transplant Population

Transplantation Proceedings

Volumn 41, Issue 6, 2009, Pages 2539-2543

  Kruger B ^a,b   Walberer, A ^a   Farkas, S ^b   Tokmak, F ^a   Obed, A ^b   Schenker, P ^c   Henning, B ^a   Schlitt, H J ^b   Kramer B K ^a,b   Banas, B ^b  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b UNIVERSITY OF REGENSBURG   (Germany)

^c RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CLADISTICS; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HUMAN; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; MORBIDITY; MORTALITY; PRIORITY JOURNAL;

EID: 68949198788     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2009.06.123     Document Type: Article

References (32)

1. Krämer B.K., Montagnino G., Del Castillo D., et al. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results. Nephrol Dial Transplant 20 (2005) 968
2. Vitko S., Klinger M., Salmela K., et al. Two corticosteroid-free regimens-tacrolimus monotherapy after basiliximab administration and tacrolimus/mycophenolate mofetil-in comparison with a standard triple regimen in renal transplantation: results of the Atlas study. Transplantation 80 (2005) 1734
3. Magee C.C., and Pascual M. Update in renal transplantation. Arch Intern Med 164 (2004) 1373
4. Ojo A.O., Hanson J.A., Wolfe R.A., et al. Long-term survival in renal transplant recipients with graft function. Kidney Int 57 (2000) 307
5. Hansson G.K. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 352 (2005) 1685
6. Seino Y., Ikeda U., Ikeda M., et al. Interleukin 6 gene transcripts are expressed in human atherosclerotic lesions. Cytokine 6 (1994) 87
7. Ridker P.M., Rifai N., Stampfer M.J., et al. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 101 (2000) 1767
8. Georges J.L., Loukaci V., Poirier O., et al. Interleukin-6 gene polymorphisms and susceptibility to myocardial infarction: the ECTIM study. Etude Cas-Temoin de l'Infarctus du Myocarde. J Mol Med 79 (2001) 300
9. Humphries S.E., Luong L.A., Ogg M.S., et al. The interleukin-6 -174 G/C promoter polymorphism is associated with risk of coronary heart disease and systolic blood pressure in healthy men. Eur Heart J 22 (2001) 2243
10. Jenny N.S., Tracy R.P., Ogg M.S., et al. In the elderly, interleukin-6 plasma levels and the -174G > C polymorphism are associated with the development of cardiovascular disease. Arterioscler Thromb Vasc Biol 22 (2002) 2066
11. Jones K.G., Brull D.J., Brown L.C., et al. Interleukin-6 (IL-6) and the prognosis of abdominal aortic aneurysms. Circulation 103 (2001) 2260
12. Nauck M., Winkelmann B.R., Hoffmann M.M., et al. The interleukin-6 G(-174)C promoter polymorphism in the LURIC cohort: no association with plasma interleukin-6, coronary artery disease, and myocardial infarction. J Mol Med 80 (2002) 507
13. Yamada Y., Izawa H., Ichihara S., et al. Prediction of the risk of myocardial infarction from polymorphisms in candidate genes. N Engl J Med 347 (2002) 1916
14. Hahn A.B., Kasten-Jolly J.C., Constantino D.M., et al. TNF-alpha, IL-6, IFN-gamma, and IL-10 gene expression polymorphisms and the IL-4 receptor alpha-chain variant Q576R: effects on renal allograft outcome. Transplantation 72 (2001) 660
15. Hutchings A., Guay-Woodford L., Thomas J.M., et al. Association of cytokine single nucleotide polymorphisms with B7 costimulatory molecules in kidney allograft recipients. Pediatr Transplant 6 (2002) 69
16. Marshall S.E., McLaren A.J., Haldar N.A., et al. The impact of recipient cytokine genotype on acute rejection after renal transplantation. Transplantation 70 (2000) 1485
17. Müller-Steinhardt M., Hartel C., Müller B., et al. The interleukin-6 -174promoter polymorphism is associated with long-term kidney allograft survival. Kidney Int 62 (2002) 1824
18. Brull D.J., Montgomery H.E., Sanders J., et al. Interleukin-6 gene -174g > c and -572g > c promoter polymorphisms are strong predictors of plasma interleukin-6 levels after coronary artery bypass surgery. Arterioscler Thromb Vasc Biol 21 (2001) 1458
19. Fishman D., Faulds G., Jeffery R., et al. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 102 (1998) 1369
20. Terry C.F., Loukaci V., and Green F.R. Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation. J Biol Chem 275 (2000) 18138
21. Liu Y., Berthier-Schaad Y., Fallin M.D., et al. IL-6 haplotypes, inflammation, and risk for cardiovascular disease in a multiethnic dialysis cohort. J Am Soc Nephrol 17 (2006) 863
22. Krüger B., Böger C.A., Schröppel B., et al. Impact of NOD2/CARD15 haplotypes on the outcome after kidney transplantation. Transpl Int 20 (2007) 600
23. Krüger B., Böger C.A., Schröppel B., et al. No effect of C-reactive protein (CRP) haplotypes on CRP levels and post-transplant morbidity and mortality in renal transplantation. Transpl Int 21 (2008) 452
24. Stephens M., and Donnelly P. A comparison of bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet 73 (2003) 1162
25. Stephens M., Smith N.J., and Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 68 (2001) 978
26. Krüger B., Schnitzbauer A.A., Böger C.A., et al. Pretransplant calcium levels have no predictive value for delayed graft function, long-term graft function, cardiovascular events, or graft and patient survival in renal transplantation. Transplant Proc 38 (2006) 697
27. Perico N., Cattaneo D., Sayegh M.H., et al. Delayed graft function in kidney transplantation. Lancet 364 (2004) 1814
28. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39 (2002) S1
29. Breulmann B., Bantis C., Siekierka M., et al. Influence of cytokine genes polymorphisms on long-term outcome in renal transplantation. Clin Transplant 21 (2007) 615
30. Harris T.B., Ferrucci L., Tracy R.P., et al. Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am J Med 106 (1999) 506
31. Danesh J., Kaptoge S., Mann A.G., et al. Long-term interleukin-6 levels and subsequent risk of coronary heart disease: two new prospective studies and a systematic review. PLoS Med 5 (2008) e78
32. Hulkkonen J., Lehtimaki T., Mononen N., et al. Polymorphism in the IL6 promoter region is associated with the risk factors and markers of subclinical atherosclerosis in men: The Cardiovascular Risk in Young Finns Study. Atherosclerosis 203 (2009) 454